Abstract: The present invention is directed to a one part, sealant composition preferably comprising a free isocyanate functionalized polyacrylate. The unblocked isocyanate is surprisingly stable even in the presence of a blocked amine curing agent. Upon exposure to ambient conditions, the blocked amine will react with ambient humidity to provide an amine which in turn will react with the polyacrylate isocyanate, thereby curing the sealant and providing exceptional sealant properties. The most preferred blocked amine curative is a ketimine.

Abstract: The invention discloses a method of preparing a silver salt of an organic acid comprising the steps of:(A) preparing a mixture of:(1) at least one organic carboxylic acid,(2) a hydrocarbon solvent, and(3) a mineral acid; and(B) adding a source of silver cation while maintaining the temperature of the resultant mixture between about 60.degree. C. and below the decomposition temperature of the components and product for a period of time sufficient to form the desired silver salt.

Abstract: Valuable pyridazinone intermediates to pharmaceutically useful compounds can be prepared in surprisingly high yields by the reaction of the corresponding monohydrazone with diketene, preferably in the presence of a basic catalyst. In an especially preferred embodiment, p,p'-dichlorobenzil monohydrazone and diketene are reacted in a xylene solvent in the presence of triethylamine to afford 4-acetyl-5,6-bis(p-chlorophenyl)-2H-pyridazin-3-one, which can then be reacted with ethylene carbonate in the presence of potassium carbonate to afford the antihypertensive agent, 4-acetyl-5,6-bis(p-chlorophenyl)-2-(2'-hydroxyethyl)-2H-pyridazine-3-one.

Abstract: Valuable pyridazinone intermediates to pharmaceutically useful compounds can be prepared in surprisingly high yields by the quinoline catalyzed reaction of the corresponding monohydrazone with an appropriately substituted acetic acid ester. In an especially preferred embodiment, p,p'-dichlorobenzil monohydrazone and methyl acetoacetate are reacted in a xylene solvent in the presence of quinoline to afford 4-acetyl-5,6-bis(p-chlorophenyl)-2H-pyridazin-3-one, which can then be reacted with ethylene carbonate in the presence of potassium carbonate to afford the antihypertensive agent, 4-acetyl-5,6-bis(p-chlorophenyl)-2-(2'-hydroxyethyl)-2H-pyridazin-3-one.